top of page


Epilepsy Drug Shows Promise for Sleep Apnea: Researchers Explore a New Treatment Approach
Researchers are exploring the option of treating sleep apnea with medications used to treat epilepsy. These medications help to overactive nerve in the brain. According to researchers, the muscles and breathing patterns used during sleep can also be stabilized by this action. Because the airways close or the brain fails to signal proper breathing, breathing stops and starts repeatedly in sleep apnea. Epilepsy drugs can reduce these disturbances by improving brain-breathing mu
-
15 hours ago2 min read


Wegovy Market Shift: Hims & Hers Shares Jump After Novo Nordisk Drops Patent Case Over Compounded Weight-Loss Drugs
Shares in Hims & Hers Health rose after Novo Nordisk withdrew a patent lawsuit related to combination drugs for weight loss. The controversy began when Novo Nordisk accused the telehealth company of selling mixed versions of its GLP-1 drugs, including Vegovy and Ozempic. The companies later reached a new agreement that allows Hims & Hers to offer Novo's FDA-approved drugs through its platform. Hims & Hers will stop advertising GLP-1 combination treatments because it is the p
-
2 days ago2 min read


Hims and Novo Nordisk Resolve Dispute to Sell Obesity Drugs Together, Expanding GLP-1 Market Access
Novo Nordisk and His & Hers Health have formed a new alliance to sell obesity medications after resolving their legal disputes. The program provides patients with access to Novo Nordisk's well-known GLP-1 weight loss medications, such as Vegovy and Ozempic, via Hims' telemedicine platform. Due to patent and safety issues, Novo Nordisk sued Himes for marketing mixed formulations of semaglutide, the active component in these medications. As part of the new agreement, Himes will
-
4 days ago3 min read
bottom of page
